Blood-brain barrier and retroviral infections

References

• Romero JR, Newland JG. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis 2003; 14:72 - 82; http://dx.doi.org/10.1053/spid.2003.127223; PMID: 12881794
   PubMedGoogle Scholar
• Ceccaldi PE, Gillet JP, Tsiang H. Inhibition of the transport of rabies virus in the central nervous system. J Neuropathol Exp Neurol 1989; 48:620 - 30; http://dx.doi.org/10.1097/00005072-198911000-00004; PMID: 2477505
   PubMed Web of Science ®Google Scholar
• Ceccaldi PE, Lucas M, Despres P. New insights on the neuropathology of West Nile virus. FEMS Microbiol Lett 2004; 233:1 - 6; http://dx.doi.org/10.1016/j.femsle.2004.01.035; PMID: 15098543
   PubMed Web of Science ®Google Scholar
• Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 2011; 12:169 - 82; http://dx.doi.org/10.1038/nrn2995; PMID: 21331083
   PubMed Web of Science ®Google Scholar
• Cipolla MJ. The Cerebral Circulation. San Rafael (CA), 2009.
   Google Scholar
• Zlokovic BV. Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends Neurosci 2005; 28:202 - 8; http://dx.doi.org/10.1016/j.tins.2005.02.001; PMID: 15808355
   PubMed Web of Science ®Google Scholar
• Pan W, Kastin AJ. Why study transport of peptides and proteins at the neurovascular interface. Brain Res Brain Res Rev 2004; 46:32 - 43; http://dx.doi.org/10.1016/j.brainresrev.2004.04.006; PMID: 15297153
   PubMed Web of Science ®Google Scholar
• Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res 2003; 61:39 - 78; PMID: 14674608
   PubMedGoogle Scholar
• Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967; 34:207 - 17; http://dx.doi.org/10.1083/jcb.34.1.207; PMID: 6033532
   PubMed Web of Science ®Google Scholar
• Bonkowski D, Katyshev V, Balabanov RD, Borisov A, Dore-Duffy P. The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival. Fluids Barriers CNS 2011; 8:8; http://dx.doi.org/10.1186/2045-8118-8-8; PMID: 21349156
   PubMedGoogle Scholar
• Nag S. Morphology and properties of astrocytes. Methods Mol Biol 2011; 686:69 - 100; http://dx.doi.org/10.1007/978-1-60761-938-3_3; PMID: 21082367
   PubMedGoogle Scholar
• Weiss N, Miller F, Cazaubon S, Couraud PO. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 2009; 1788:842 - 57; http://dx.doi.org/10.1016/j.bbamem.2008.10.022; PMID: 19061857
   PubMed Web of Science ®Google Scholar
• Correale J, Villa A. Cellular elements of the blood-brain barrier. Neurochem Res 2009; 34:2067 - 77; http://dx.doi.org/10.1007/s11064-009-0081-y; PMID: 19856206
   PubMed Web of Science ®Google Scholar
• Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 1969; 40:648 - 77; http://dx.doi.org/10.1083/jcb.40.3.648; PMID: 5765759
   PubMed Web of Science ®Google Scholar
• Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 2001; 46:247 - 79; http://dx.doi.org/10.1016/S0169-409X(00)00139-3; PMID: 11259843
   PubMed Web of Science ®Google Scholar
• Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 2005; 6:591 - 602; http://dx.doi.org/10.1038/nrn1728; PMID: 16025095
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Wolburg H. Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house?. Eur J Immunol 2004; 34:2955 - 63; http://dx.doi.org/10.1002/eji.200425327; PMID: 15376193
   PubMed Web of Science ®Google Scholar
• Nassif X, Bourdoulous S, Eugène E, Couraud PO. How do extracellular pathogens cross the blood-brain barrier?. Trends Microbiol 2002; 10:227 - 32; http://dx.doi.org/10.1016/S0966-842X(02)02349-1; PMID: 11973156
   PubMed Web of Science ®Google Scholar
• Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992; 42:1472 - 6; PMID: 1641138
   PubMed Web of Science ®Google Scholar
• Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc 2002; 8:410 - 24; http://dx.doi.org/10.1017/S1355617702813212; PMID: 11939699
   PubMed Web of Science ®Google Scholar
• Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19:525 - 35; http://dx.doi.org/10.1002/ana.410190603; PMID: 3014994
   PubMed Web of Science ®Google Scholar
• Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986; 19:517 - 24; http://dx.doi.org/10.1002/ana.410190602; PMID: 3729308
   PubMed Web of Science ®Google Scholar
• Wiley CA, Schrier RD, Morey M, Achim C, Venable JC, Nelson JA. Pathogenesis of HIV encephalitis. Acta Pathol Jpn 1991; 41:192 - 6; PMID: 2068943
   PubMedGoogle Scholar
• Toborek M, Lee YW, Flora G, Pu H, András IE, Wylegala E, et al. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol 2005; 25:181 - 99; http://dx.doi.org/10.1007/s10571-004-1383-x; PMID: 15962513
   PubMed Web of Science ®Google Scholar
• Budka H. The definition of HIV-specific neuropathology. Acta Pathol Jpn 1991; 41:182 - 91; PMID: 2068942
   PubMedGoogle Scholar
• Tardieu M. HIV-1-related central nervous system diseases. Curr Opin Neurol 1999; 12:377 - 81; http://dx.doi.org/10.1097/00019052-199908000-00002; PMID: 10555824
   PubMed Web of Science ®Google Scholar
• Singer EJ, Syndulko K, Fahy-Chandon B, Schmid P, Conrad A, Tourtellotte WW. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquir Immune Defic Syndr 1994; 7:265 - 71; PMID: 7906304
   PubMed Web of Science ®Google Scholar
• Avison MJ, Nath A, Berger JR. Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance?. Trends Neurosci 2002; 25:468 - 73; http://dx.doi.org/10.1016/S0166-2236(02)02234-8; PMID: 12183208
   PubMed Web of Science ®Google Scholar
• Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999; 155:1915 - 27; http://dx.doi.org/10.1016/S0002-9440(10)65511-3; PMID: 10595922
   PubMed Web of Science ®Google Scholar
• Boven LA, Middel J, Verhoef J, De Groot CJ, Nottet HS. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol Appl Neurobiol 2000; 26:356 - 60; http://dx.doi.org/10.1046/j.1365-2990.2000.00255.x; PMID: 10931369
   PubMed Web of Science ®Google Scholar
• Mogensen TH, Paludan SR. Virus-cell interactions: impact on cytokine production, immune evasion and tumor growth. Eur Cytokine Netw 2001; 12:382 - 90; PMID: 11566618
   PubMed Web of Science ®Google Scholar
• Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 2001; 65:131 - 50; http://dx.doi.org/10.1128/MMBR.65.1.131-150.2001; PMID: 11238989
   PubMed Web of Science ®Google Scholar
• Gabuzda DH, Sobel RA. HIV antigen in brains of patients with AIDS. Ann Neurol 1987; 22:668; http://dx.doi.org/10.1002/ana.410220526; PMID: 3480698
   PubMed Web of Science ®Google Scholar
• Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998; 12:1327 - 32; http://dx.doi.org/10.1097/00002030-199811000-00014; PMID: 9708412
   PubMed Web of Science ®Google Scholar
• Bernasconi S, Cinque P, Peri G, Sozzani S, Crociati A, Torri W, et al. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J Infect Dis 1996; 174:1098 - 101; http://dx.doi.org/10.1093/infdis/174.5.1098; PMID: 8896515
   PubMed Web of Science ®Google Scholar
• Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 1999; 46:391 - 8; http://dx.doi.org/10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; PMID: 10482270
   PubMed Web of Science ®Google Scholar
• Marshall DC, Wyss-Coray T, Abraham CR. Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains. Neurosci Lett 1998; 254:97 - 100; http://dx.doi.org/10.1016/S0304-3940(98)00674-0; PMID: 9779929
   PubMed Web of Science ®Google Scholar
• Sporer B, Paul R, Koedel U, Grimm R, Wick M, Goebel FD, et al. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 1998; 178:854 - 7; http://dx.doi.org/10.1086/515342; PMID: 9728558
   PubMed Web of Science ®Google Scholar
• Weeks BS, Lieberman DM, Johnson B, Roque E, Green M, Loewenstein P, et al. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the Tat amino acid 49-58 basic domain. J Neurosci Res 1995; 42:34 - 40; http://dx.doi.org/10.1002/jnr.490420105; PMID: 8531224
   PubMed Web of Science ®Google Scholar
• Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 2000; 6:145 - 55; http://dx.doi.org/10.3109/13550280009013158; PMID: 10822328
   PubMed Web of Science ®Google Scholar
• Arese M, Ferrandi C, Primo L, Camussi G, Bussolino F. HIV-1 Tat protein stimulates in vivo vascular permeability and lymphomononuclear cell recruitment. J Immunol 2001; 166:1380 - 8; PMID: 11145723
   PubMed Web of Science ®Google Scholar
• Oshima T, Flores SC, Vaitaitis G, Coe LL, Joh T, Park JH, et al. HIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathways. AIDS 2000; 14:475 - 82; http://dx.doi.org/10.1097/00002030-200003310-00002; PMID: 10780709
   PubMed Web of Science ®Google Scholar
• Pu H, Tian J, Flora G, Lee YW, Nath A, Hennig B, et al. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol Cell Neurosci 2003; 24:224 - 37; http://dx.doi.org/10.1016/S1044-7431(03)00171-4; PMID: 14550782
   PubMed Web of Science ®Google Scholar
• András IE, Pu H, Deli MA, Nath A, Hennig B, Toborek M. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res 2003; 74:255 - 65; http://dx.doi.org/10.1002/jnr.10762; PMID: 14515355
   PubMed Web of Science ®Google Scholar
• Toborek M, Lee YW, Pu H, Malecki A, Flora G, Garrido R, et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J Neurochem 2003; 84:169 - 79; http://dx.doi.org/10.1046/j.1471-4159.2003.01543.x; PMID: 12485413
   PubMed Web of Science ®Google Scholar
• Shi B, De Girolami U, He J, Wang S, Lorenzo A, Busciglio J, et al. Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest 1996; 98:1979 - 90; http://dx.doi.org/10.1172/JCI119002; PMID: 8903316
   PubMed Web of Science ®Google Scholar
• Acheampong EA, Parveen Z, Muthoga LW, Kalayeh M, Mukhtar M, Pomerantz RJ. Human Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspases. J Virol 2005; 79:4257 - 69; http://dx.doi.org/10.1128/JVI.79.7.4257-4269.2005; PMID: 15767427
   PubMed Web of Science ®Google Scholar
• Price TO, Ercal N, Nakaoke R, Banks WA. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 2005; 1045:57 - 63; http://dx.doi.org/10.1016/j.brainres.2005.03.031; PMID: 15910762
   PubMed Web of Science ®Google Scholar
• Kanmogne GD, Primeaux C, Grammas P. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 2005; 64:498 - 505; PMID: 15977641
   PubMed Web of Science ®Google Scholar
• Nakamuta S, Endo H, Higashi Y, Kousaka A, Yamada H, Yano M, et al. Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells. J Neurovirol 2008; 14:186 - 95; http://dx.doi.org/10.1080/13550280801993630; PMID: 18569453
   PubMed Web of Science ®Google Scholar
• Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 2007; 27:123 - 34; http://dx.doi.org/10.1038/sj.jcbfm.9600330; PMID: 16685256
   PubMed Web of Science ®Google Scholar
• Rottman JB, Ganley KP, Williams K, Wu L, Mackay CR, Ringler DJ. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am J Pathol 1997; 151:1341 - 51; PMID: 9358760
   PubMed Web of Science ®Google Scholar
• Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL. Chemokines and receptors in HIV encephalitis. AIDS 1998; 12:1021 - 6; http://dx.doi.org/10.1097/00002030-199809000-00009; PMID: 9662198
   PubMed Web of Science ®Google Scholar
• Moses AV, Bloom FE, Pauza CD, Nelson JA. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci U S A 1993; 90:10474 - 8; http://dx.doi.org/10.1073/pnas.90.22.10474; PMID: 7504264
   PubMed Web of Science ®Google Scholar
• Moses AV, Nelson JA. HIV infection of human brain capillary endothelial cells--implications for AIDS dementia. Adv Neuroimmunol 1994; 4:239 - 47; http://dx.doi.org/10.1016/S0960-5428(06)80262-7; PMID: 7533040
   PubMedGoogle Scholar
• Sporer B, Koedel U, Paul R, Kohleisen B, Erfle V, Fontana A, et al. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol 2000; 102:125 - 30; http://dx.doi.org/10.1016/S0165-5728(99)00170-8; PMID: 10636480
   PubMed Web of Science ®Google Scholar
• Rostad SW, Sumi SM, Shaw CM, Olson K, McDougall JK. Human immunodeficiency virus (HIV) infection in brains with AIDS-related leukoencephalopathy. AIDS Res Hum Retroviruses 1987; 3:363 - 73; http://dx.doi.org/10.1089/aid.1987.3.363; PMID: 3447627
   PubMed Web of Science ®Google Scholar
• Ward JM, O’Leary TJ, Baskin GB, Benveniste R, Harris CA, Nara PL, et al. Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 1987; 127:199 - 205; PMID: 3472469
   PubMed Web of Science ®Google Scholar
• Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 1986; 83:7089 - 93; http://dx.doi.org/10.1073/pnas.83.18.7089; PMID: 3018755
   PubMed Web of Science ®Google Scholar
• Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 1996; 39:705 - 11; http://dx.doi.org/10.1002/ana.410390606; PMID: 8651642
   PubMed Web of Science ®Google Scholar
• Liu Y, Tang XP, McArthur JC, Scott J, Gartner S. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol 2000; 6:Suppl 1 S70 - 81; PMID: 10871768
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005; 26:485 - 95; http://dx.doi.org/10.1016/j.it.2005.07.004; PMID: 16039904
   PubMed Web of Science ®Google Scholar
• Gras G, Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 2010; 7:30; http://dx.doi.org/10.1186/1742-4690-7-30; PMID: 20374632
   PubMed Web of Science ®Google Scholar
• Wu DT, Woodman SE, Weiss JM, McManus CM, D’Aversa TG, Hesselgesser J, et al. Mechanisms of leukocyte trafficking into the CNS. J Neurovirol 2000; 6:Suppl 1 S82 - 5; PMID: 10871769
   PubMedGoogle Scholar
• Jones MV, Bell JE, Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 2000; 14:2709 - 13; http://dx.doi.org/10.1097/00002030-200012010-00010; PMID: 11125889
   PubMed Web of Science ®Google Scholar
• Fantuzzi L, Spadaro F, Vallanti G, Canini I, Ramoni C, Vicenzi E, et al. Endogenous CCL2 (monocyte chemotactic protein-1) modulates human immunodeficiency virus type-1 replication and affects cytoskeleton organization in human monocyte-derived macrophages. Blood 2003; 102:2334 - 7; http://dx.doi.org/10.1182/blood-2002-10-3275; PMID: 12805068
   PubMed Web of Science ®Google Scholar
• Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 2002; 99:13795 - 800; http://dx.doi.org/10.1073/pnas.202357499; PMID: 12374865
   PubMed Web of Science ®Google Scholar
• Yadav A, Collman RG. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 2009; 4:430 - 47; http://dx.doi.org/10.1007/s11481-009-9174-2; PMID: 19768553
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ, Brennan JM, Vallance KL. Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp Neurol 1999; 156:165 - 71; http://dx.doi.org/10.1006/exnr.1998.7011; PMID: 10192787
   PubMed Web of Science ®Google Scholar
• Stolp HB, Dziegielewska KM, Ek CJ, Potter AM, Saunders NR. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur J Neurosci 2005; 22:2805 - 16; http://dx.doi.org/10.1111/j.1460-9568.2005.04483.x; PMID: 16324115
   PubMed Web of Science ®Google Scholar
• Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, et al. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997; 158:3499 - 510; PMID: 9120312
   PubMed Web of Science ®Google Scholar
• Wang H, Sun J, Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J Virol 2008; 82:7591 - 600; http://dx.doi.org/10.1128/JVI.00768-08; PMID: 18508884
   PubMed Web of Science ®Google Scholar
• Baskin GB, Murphey-Corb M, Watson EA, Martin LN. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet Pathol 1988; 25:456 - 67; http://dx.doi.org/10.1177/030098588802500609; PMID: 2850650
   PubMed Web of Science ®Google Scholar
• Sharer LR, Baskin GB, Cho ES, Murphey-Corb M, Blumberg BM, Epstein LG. Comparison of simian immunodeficiency virus and human immunodeficiency virus encephalitides in the immature host. Ann Neurol 1988; 23:Suppl S108 - 12; http://dx.doi.org/10.1002/ana.410230727; PMID: 2831797
   PubMedGoogle Scholar
• Chakrabarti L, Hurtrel M, Maire MA, Vazeux R, Dormont D, Montagnier L, et al. Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol 1991; 139:1273 - 80; PMID: 1750503
   PubMed Web of Science ®Google Scholar
• Hurtrel B, Chakrabarti L, Hurtrel M, Maire MA, Dormont D, Montagnier L. Early SIV encephalopathy. J Med Primatol 1991; 20:159 - 66; PMID: 1942006
   PubMed Web of Science ®Google Scholar
• Luabeya MK, Dallasta LM, Achim CL, Pauza CD, Hamilton RL. Blood-brain barrier disruption in simian immunodeficiency virus encephalitis. Neuropathol Appl Neurobiol 2000; 26:454 - 62; http://dx.doi.org/10.1046/j.1365-2990.2000.00275.x; PMID: 11054186
   PubMed Web of Science ®Google Scholar
• Ryan G, Grimes T, Brankin B, Mabruk MJ, Hosie MJ, Jarrett O, et al. Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. J Neurovirol 2005; 11:337 - 45; http://dx.doi.org/10.1080/13550280500186445; PMID: 16162477
   PubMed Web of Science ®Google Scholar
• Steffan AM, Lafon ME, Gendrault JL, Koehren F, De Monte M, Royer C, et al. Feline immunodeficiency virus can productively infect cultured endothelial cells from cat brain microvessels. J Gen Virol 1994; 75:3647 - 53; http://dx.doi.org/10.1099/0022-1317-75-12-3647; PMID: 7996160
   PubMed Web of Science ®Google Scholar
• Fletcher NF, Meeker RB, Hudson LC, Callanan JJ. The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome. Vet J 2011; 188:260 - 9; http://dx.doi.org/10.1016/j.tvjl.2010.03.022; PMID: 20418131
   PubMed Web of Science ®Google Scholar
• Georgsson G. Neuropathologic aspects of lentiviral infections. Ann N Y Acad Sci 1994; 724:50 - 67; http://dx.doi.org/10.1111/j.1749-6632.1994.tb38895.x; PMID: 8030977
   PubMed Web of Science ®Google Scholar
• Zink MC, Yager JA, Myers JD. Pathogenesis of caprine arthritis encephalitis virus. Cellular localization of viral transcripts in tissues of infected goats. Am J Pathol 1990; 136:843 - 54; PMID: 2327471
   PubMed Web of Science ®Google Scholar
• Osame M, Izumo S, Igata A, Matsumoto M, Matsumoto T, Sonoda S, et al. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986; 2:104 - 5; http://dx.doi.org/10.1016/S0140-6736(86)91636-3; PMID: 2873363
   PubMed Web of Science ®Google Scholar
• Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1:1031 - 2; http://dx.doi.org/10.1016/S0140-6736(86)91298-5; PMID: 2871307
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2:407 - 10; http://dx.doi.org/10.1016/S0140-6736(85)92734-5; PMID: 2863442
   PubMed Web of Science ®Google Scholar
• Jernigan M, Morcos Y, Lee SM, Dohan FC Jr., Raine C, Levin MC. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology 2003; 60:1320 - 7; PMID: 12707436
   PubMed Web of Science ®Google Scholar
• Ozden S, Seilhean D, Gessain A, Hauw JJ, Gout O. Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient. Clin Infect Dis 2002; 34:855 - 60; http://dx.doi.org/10.1086/338868; PMID: 11830796
   PubMed Web of Science ®Google Scholar
• Cartier L, Ramirez E. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients. Arch Virol 2005; 150:743 - 53; http://dx.doi.org/10.1007/s00705-004-0443-3; PMID: 15592888
   PubMed Web of Science ®Google Scholar
• Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 2000; 182:1044 - 50; http://dx.doi.org/10.1086/315844; PMID: 10979898
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Matsui M, Takashima H, Kurohara K. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy. J Neuroimmunol 1993; 45:133 - 6; http://dx.doi.org/10.1016/0165-5728(93)90173-V; PMID: 8331158
   PubMed Web of Science ®Google Scholar
• Kuroda Y, Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42:223 - 6; http://dx.doi.org/10.1016/0165-5728(93)90014-P; PMID: 8429106
   PubMed Web of Science ®Google Scholar
• Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42:127 - 30; http://dx.doi.org/10.1016/0165-5728(93)90001-F; PMID: 8429097
   PubMed Web of Science ®Google Scholar
• Brosnan CF, Selmaj K, Raine CS. Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol 1988; 18:87 - 94; http://dx.doi.org/10.1016/0165-5728(88)90137-3; PMID: 3257971
   PubMed Web of Science ®Google Scholar
• Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 37:167 - 75; http://dx.doi.org/10.1002/ana.410370206; PMID: 7847858
   PubMed Web of Science ®Google Scholar
• Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002; 186:Suppl 2 S187 - 92; http://dx.doi.org/10.1086/344269; PMID: 12424696
   PubMedGoogle Scholar
• Muller S, Boire G, Ossondo M, Ricchiuti V, Smadja D, Vernant JC, et al. IgG autoantibody response in HTLV-I-infected patients. Clin Immunol Immunopathol 1995; 77:282 - 90; http://dx.doi.org/10.1006/clin.1995.1154; PMID: 7586738
   PubMedGoogle Scholar
• Romero IA, Prevost MC, Perret E, Adamson P, Greenwood J, Couraud PO, et al. Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 2000; 74:6021 - 30; http://dx.doi.org/10.1128/JVI.74.13.6021-6030.2000; PMID: 10846084
   PubMed Web of Science ®Google Scholar
• Afonso PV, Ozden S, Prevost MC, Schmitt C, Seilhean D, Weksler B, et al. Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol 2007; 179:2576 - 83; PMID: 17675520
   PubMed Web of Science ®Google Scholar
• Khuth ST, Strazielle N, Giraudon P, Belin MF, Ghersi-Egea JF. Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J Neurochem 2005; 94:1580 - 93; http://dx.doi.org/10.1111/j.1471-4159.2005.03309.x; PMID: 16026393
   PubMed Web of Science ®Google Scholar
• Afonso PV, Ozden S, Cumont MC, Seilhean D, Cartier L, Rezaie P, et al. Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog 2008; 4:e1000205; http://dx.doi.org/10.1371/journal.ppat.1000205; PMID: 19008946
   PubMed Web of Science ®Google Scholar
• Lezin A, Gillet N, Olindo S, Signaté A, Grandvaux N, Verlaeten O, et al. Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients. Blood 2007; 110:3722 - 8; http://dx.doi.org/10.1182/blood-2007-04-085076; PMID: 17717136
   PubMed Web of Science ®Google Scholar
• Boissé L, Gill MJ, Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 2008; 26:799 - 819, x; http://dx.doi.org/10.1016/j.ncl.2008.04.002; PMID: 18657727
   PubMed Web of Science ®Google Scholar
• Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. Int Rev Psychiatry 2008; 20:15 - 24; http://dx.doi.org/10.1080/09540260701862037; PMID: 18240059
   PubMed Web of Science ®Google Scholar
• Mahajan SD, Aalinkeel R, Sykes DE, Reynolds JL, Bindukumar B, Fernandez SF, et al. Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability. J Clin Immunol 2008; 28:528 - 41; http://dx.doi.org/10.1007/s10875-008-9208-1; PMID: 18574677
   PubMed Web of Science ®Google Scholar
• Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, et al. Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol 1998; 4:619 - 26; http://dx.doi.org/10.3109/13550289809114228; PMID: 10065903
   PubMed Web of Science ®Google Scholar
• Fiala M, Gan XH, Zhang L, House SD, Newton T, Graves MC, et al. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine’s connection to AIDS dementia and vasculitis?. Adv Exp Med Biol 1998; 437:199 - 205; http://dx.doi.org/10.1007/978-1-4615-5347-2_22; PMID: 9666272
   PubMed Web of Science ®Google Scholar
• Gandhi N, Saiyed ZM, Napuri J, Samikkannu T, Reddy PV, Agudelo M, et al. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder. J Neurovirol 2010; 16:294 - 305; http://dx.doi.org/10.3109/13550284.2010.499891; PMID: 20624003
   PubMed Web of Science ®Google Scholar
• Lu TS, Avraham HK, Seng S, Tachado SD, Koziel H, Makriyannis A, et al. Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol 2008; 181:6406 - 16; PMID: 18941231
   PubMed Web of Science ®Google Scholar
• Manda VK, Mittapalli RK, Bohn KA, Adkins CE, Lockman PR. Nicotine and cotinine increases the brain penetration of saquinavir in rat. J Neurochem 2010; 115:1495 - 507; http://dx.doi.org/10.1111/j.1471-4159.2010.07054.x; PMID: 20950334
   PubMed Web of Science ®Google Scholar
• Manda VK, Mittapalli RK, Geldenhuys WJ, Lockman PR. Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity. J Neurochem 2010; 115:515 - 25; http://dx.doi.org/10.1111/j.1471-4159.2010.06948.x; PMID: 20722969
   PubMed Web of Science ®Google Scholar